Rapivab is an intravenous treatment for severe flu, approved this month for children aged 2-18. It has been used for adults for almost three years.
Rapivab is an intravenous treatment for severe flu, approved this month for children aged 2-18. It has been used for adults for almost three years. Andrea Reese Photography BioCryst Pharmaceuticals
Rapivab is an intravenous treatment for severe flu, approved this month for children aged 2-18. It has been used for adults for almost three years. Andrea Reese Photography BioCryst Pharmaceuticals

If you get the flu, this drug can save your life. Now it’s approved for your kids.

September 29, 2017 11:13 AM